Apparatus and methods of inducing weight loss using blood flow control

ABSTRACT

Methods and apparatus for inducing weight loss using blood flow control are described herein. The apparatus and methods operate by controlling blood flow to the stomach and/or small bowel.

RELATED APPLICATION

The present application claims the benefit under 35 U.S.C. § 119(e) ofU.S. Provisional Patent Application No. 61/949,024, filed on Mar. 6,2014 and titled APPARATUS AND METHODS OF INDUCING WEIGHT LOSS USINGBLOOD FLOW CONTROL, which is hereby incorporated by reference in itsentirety.

Apparatus and methods of inducing weight loss using blood flow controlare described herein. The apparatus and methods operate by controllingblood flow to the stomach and/or small bowel.

Morbid obesity and its concurrent health risks (including diabetes,heart disease and other ailments) are of near-epidemic proportions inindustrialized societies. A wide variety of treatments have beenproposed and attempted to treat morbid obesity with a wide variety ofefficacy and associated morbidity. These treatments include techniquesto reduce stomach volume, alter gastric and intestinal motility, andalter the absorption of nutrients in the small intestine.

Clearly, obesity is a complex disease having physiologic, social andpsychological components which are not fully understood. The complexnature and the enormous societal implication of obesity require a widevariety of treatment options be available to permit a physician toselect a most appropriate option for a particular patient.

Even if all treatments were proven effective, no one treatment can meetthe clinical needs presented by a diverse population. For example,bariatric surgeries, such as the Roux-en-Y procedure as will bedescribed, is not considered suitable for only so-called mildly obesepatients (e.g., those with a Body Mass Index less than 35).

Less invasive procedures (such as gastric banding) have reduced surgicalrisk. Unfortunately, they suffer from reduced efficacy (and they are notwithout risks). Further, efficacy may be culturally biased. Namely,gastric banding studies show reduced efficacy in North American patientscompared to European patients.

Surgical approaches may include, e.g., minimally invasive surgery, opensurgery and endoscopic approaches to gastric volume reduction. Gastricvolume reduction procedures include vertical and horizontal gastroplastyin which sutures, staples or other fixation devices are used to joinopposing surfaces of the stomach to create a reduced volume pouch andthereby reduce caloric intake. Less invasive techniques for restrictingthe volume of the stomach also include a gastric partition in which thestomach wall is endoscopically cinched together to form a reduced sizepouch. Other techniques for reducing gastric volume size includeplacement of obstructions within the stomach.

To address deficiencies associated with gastric volume reduction,treatments have been suggested and developed for reducing the amount ofnutrient absorption in the small intestine (particularly in the upperand middle portions of the small intestine—the duodenum and jejunum,respectively). Techniques to reduce nutrient absorption (commonlyreferred to as malabsorption treatments) include drug therapies forreducing lipids absorption.

Other malabsorption treatments include surgical techniques for reroutingthe intestinal system to bypass an extended portion of the smallintestine. These include a so-called jejunoileal bypass. Not commonlyused due to unacceptable mortality rates, a jejunoileal bypass typicallyresults in effective weight loss. Other techniques include the gastricbypass (or Roux-en Y) and duodenal switch. As a result, the absorptivelength of the small intestine is significantly shortened therebyreducing the amount of nutrients which are absorbed into the body andwhich support or lead to weight gain. These procedures combine thebenefits of gastric volume reduction with malabsorption.

Less invasive techniques are suggested for placing a band (referred toas LAP bands) around an upper portion of the stomach to act as a belt toreduce the size of the stomach and create a small passageway (a stoma)from a small upper pouch to the remainder of the stomach.

US Patent Application Publication No. US 2013/0184635 describes avariety of techniques for treating obesity which may include one or moreof reducing the rate of stomach emptying, creating a fistula between thestomach and another portion of the gastrointestinal tract two limitnutrient absorption, etc.

US Patent Application Publication No. US 2013/0096580 describes anotherapproach to obesity treatment which involves occluding a blood vessel tointerfere with normal gastrointestinal function.

SUMMARY

Methods and apparatus for inducing weight loss using blood flow controlare described herein. The apparatus and methods operate by controllingblood flow to the stomach and/or small bowel.

In a first aspect, one or more embodiments of a method of inducingweight loss as described herein may include: making a determination thata patient is ingesting food; and reducing blood flow to thegastrointestinal tract after making the determination that a patient isingesting food.

In one or more embodiments of methods according to the first aspect,making a determination that a patient is ingesting food comprises one ormore of: sensing distention of the patient's stomach, sensing increasedpressure in the patient's stomach, sensing swallowing by the patient,receiving direct feedback from the user, and Doppler flow measurementsto measure flow velocity.

In one or more embodiments of methods according to the first aspect,reducing blood flow to the gastrointestinal tract comprises mechanicallyconstricting one or more blood vessels that supply the stomach and/orsmall bowel.

In one or more embodiments of methods according to the first aspect,reducing blood flow to the gastrointestinal tract comprises cooling anexterior surface of one or more blood vessels that supply the stomachand/or small bowel. In one or more embodiments, cooling an exteriorsurface of one or more blood vessels that supply the stomach and/orsmall bowel comprises coiling a cooling device around the one or moreblood vessels that supply the stomach and/or small bowel.

In one or more embodiments of methods according to the first aspect,reducing blood flow to the gastrointestinal tract comprises coolingblood flowing through one or more blood vessels supplying blood to thestomach and/or the small bowel. In one or more embodiments, the coolingcomprises locating a perfusion balloon in a blood vessel and supplyingcooling fluid within the perfusion balloon to reduce the temperature ofblood flowing through the blood vessel past the perfusion balloon.

In one or more embodiments of methods according to the first aspect,reducing blood flow to the gastrointestinal tract comprises: sensing anincrease in blood flow in one or more gastric supply blood vessels; anddiverting flow away from the one or more blood vessels that supply thestomach and/or small bowel after sensing the increase in blood flow inthe one or more blood vessels that supply the stomach and/or smallbowel.

In one or more embodiments of methods according to the first aspect,reducing blood flow to the gastrointestinal tract comprises eluting adrug to reduce flow through one or more blood vessels that supply thestomach and/or small bowel.

In one or more embodiments of methods according to the first aspect,reducing blood flow to the gastrointestinal tract comprises expandingone or more blood vessels that do not that supply the stomach and/orsmall bowel.

In one or more embodiments of methods according to the first aspect,reducing blood flow to the gastrointestinal tract comprises reducing theflow of blood away from the gastrointestinal tract.

In one or more embodiments of methods according to the first aspect,reducing blood flow to the gastrointestinal tract comprises cooling oneor more of: stomach, small bowel, and nerves associated with the stomachand/or small bowel.

In a second aspect, one or more embodiments of a method of inducingweight loss as described herein may include reducing blood flow to thegastrointestinal tract by ablating one or more blood vessels that supplythe stomach and/or small bowel to limit dilation of the blood vessels toincrease flow after the ablating.

In one or more embodiments of methods according to the second aspect,the ablating is configured to cause fibrosis of the one or more bloodvessels that supply the stomach and/or small bowel, wherein the fibrosislimits dilation of the blood vessels to increase flow.

In a third aspect, one or more embodiments of a method of inducingweight loss as described herein may include reducing blood flow to thegastrointestinal tract by ablating one or more nerves selected from thegroup of: celiac ganglion, superior mesenteric, inferior mesenteric, andhepatic.

In one or more embodiments of methods according to the third aspect, theablating comprises ablating the one or more nerves using one or more of:direct current electroporation, microwave energy, and radio-frequencyenergy.

In a fourth aspect, one or more embodiments of a method of inducingweight loss as described herein may include reducing blood flow to thegastrointestinal tract by stimulating one or more peri-arterial nervesto cause vasoconstriction of one or more blood vessels that supply thestomach and/or small bowel.

In a fifth aspect, one or more embodiments of a method of inducingweight loss as described herein may include reducing blood flow to thegastrointestinal tract by pacing one or more peri-arterial nerves tocause vasoconstriction of one or more blood vessels that supply thestomach and/or small bowel.

In a sixth aspect, one or more embodiments of a system for inducingweight loss as described herein may include: a controller operablyconnected to one or more input devices, wherein the controller isconfigured to determine that a patient is ingesting food; and one ormore blood flow constriction devices operably connected to thecontroller, the one or more blood flow constriction devices configuredto reduce blood flow to the gastrointestinal tract.

In one or more embodiments of systems according to the sixth aspect, theone or more input devices comprise one or more of: a sensor configuredto detect distention and/or increased pressure in a stomach, a sensorconfigured to detect swallowing, and a sensor configured to detect flowinto a stomach.

In one or more embodiments of systems according to the sixth aspect, theone or more input devices comprise a direct input device actuated by apatient to provide a signal to the controller that food is beingingested.

In one or more embodiments of systems according to the sixth aspect, theone or more blood flow constriction devices comprises a deviceconfigured to mechanically constrict one or more blood vessels thatsupply the stomach and/or small bowel.

In one or more embodiments of systems according to the sixth aspect, theone or more blood flow constriction devices comprises a deviceconfigured to cool an exterior surface of one or more blood vessels thatsupply the stomach and/or small bowel. In one or more embodiments, theone or more blood flow constriction devices is coiled around theexterior surface of the one or more blood vessels that supply thestomach and/or small bowel.

In one or more embodiments of systems according to the sixth aspect, theone or more blood flow constriction devices comprises a perfusionballoon configured to cool blood flowing through a blood vessel in whichthe perfusion balloon is located.

As used herein and in the appended claims, the singular forms “a,” “an,”and “the” include plural referents unless the context clearly dictatesotherwise. Thus, for example, reference to “a” or “the” component mayinclude one or more of the components and equivalents thereof known tothose skilled in the art. Further, the term “and/or” means one or all ofthe listed elements or a combination of any two or more of the listedelements.

It is noted that the term “comprises” and variations thereof do not havea limiting meaning where these terms appear in the accompanyingdescription. Moreover, “a,” “an,” “the,” “at least one,” and “one ormore” are used interchangeably herein.

The above summary is not intended to describe each embodiment or everyimplementation of the obesity treatment apparatus or methods describedherein. Rather, a more complete understanding of the invention willbecome apparent and appreciated by reference to the followingDescription of Illustrative Embodiments and claims in view of theaccompanying figures of the drawing.

BRIEF DESCRIPTION OF THE VIEWS OF THE DRAWING

FIG. 1 is a flowchart depicting one illustrative embodiment of a methodof inducing weight loss as described herein.

FIG. 2 depicts one illustrative embodiment of an apparatus that may beused to induce weight loss as described herein.

FIG. 3 depicts one illustrative embodiment of an apparatus and methodfor cooling blood within a blood vessel as described herein.

DESCRIPTION OF ILLUSTRATIVE EMBODIMENTS

In the following description of illustrative embodiments, reference ismade to the accompanying figures of the drawing which form a parthereof, and in which are shown, by way of illustration, specificembodiments. It is to be understood that other embodiments may beutilized and structural changes may be made without departing from thescope of the present invention.

On illustrative embodiment of a method of inducing weight loss isdepicted in a flowchart in FIG. 1. In one or more embodiments, themethod includes (10) making a determination that a patient is ingestingfood, followed by (12) reducing blood flow to the gastrointestinal tractafter making the determination that a patient is ingesting food. Inother words, control over blood flow to the gastrointestinal tract isbased on making a determination that a patient is ingesting food.

That determination, i.e., that a patient is ingesting food can be madeby any of a variety of techniques. In one or more embodiments,determining that a patient is ingesting food may be accomplished througha variety of techniques such as, e.g., using a sensor to detectdistention of and/or increased pressure in the stomach (using, e.g.,pressure sensors, etc.), sensing swallowing by the patient, detectingflow of food into the stomach, detecting changes in luminal fluid (e.g.acidity, bile acid content, fluid volume, solid material), detectingpatient activity or movement versus a resting state, detectinggastrointestinal (GI) luminal wall characteristics (e.g. stiffness,thickness), detecting positional changes of recumbency versus standing,etc., and combinations of one or more of these techniques. In one ormore alternative embodiments, a patient may provide direct feedback,i.e., an indication that he or she is ingesting food directly asdescribed elsewhere herein. In one or more alternative embodiments, thesystem can also be selectively and automatically triggered based ontime.

Once a determination is made that a patient is ingesting food, one ormore embodiments of the methods described herein may include reducingblood flow to one or more portions of the gastrointestinal tract.Reducing blood flow to one or more portions of the gastrointestinaltract may, in one or more embodiments, slow the passage of food throughthe gastrointestinal tract. Slowing the passage of food out of thestomach may increase the feelings of satiety experienced by the patientwhich may, in turn, lead to a reduction in food consumption.

In one or more embodiments of the methods described herein, reducingblood flow to the gastrointestinal tract may include mechanicallyconstricting one or more blood vessels that supply the stomach and/orsmall bowel. Although US Patent Application Publication No. US2013/0096580 describes obesity treatment methods that involve occludinga blood vessel to interfere with normal gastrointestinal function, thosemethods are static. In other words, those methods do not includerestricting blood flow in response to determining that a patient isingesting food. The various apparatus and techniques for mechanicallyconstricting blood vessels that supply the stomach and/or small boweldescribed in that reference may, however, be useful in connection withthe methods described herein. Other methods of mechanical constrictionmay also be used for occluding blood flow, for example, air or fluidfilled inflatable cuffs, magnetic devices, a lever- or hinge-basedsystem, vessel retraction toward an anchored structure (e.g. spine),etc.

In one or more embodiments, flow manipulating devices used to reduceblood flow to the gastrointestinal tract may be placed internally orexternally in or around a target vessel. These placements could be,e.g., percutaneous, transmural by traversing intestinal wall, via thevasculature or through a laparoscopic or retroperitoneal approach. Inone or more embodiments, the flow manipulating devices could include astimulation system (electrodes, wires, or pneumatic cuff) that, e.g.,stimulates nerves that, in turn, constrict the vessel. In one or moreembodiments, the flow manipulating devices could include a stimulationsystem that stimulates the smooth muscle of the vessel and give rise toconstriction. In one or more embodiments, the flow manipulating devicesmay also be utilized in a non-muscular constriction system made up ofconformable metals, metalloids, or engineered materials that result inconstriction and apposition when electrically stimulated.

Another option for one or more embodiments of a flow manipulating deviceinvolves the use of a pneumatic compression device with the aircompression chamber involving a diaphragm with one surface exposed tothe ring around the vessel of interest and the other to an externalcompression chamber that could, e.g., be placed subcutaneously or withinthe abdominal cavity. In one or more embodiments, the pneumatic chambermay involve a system where there is no direct air transport, but ratheran electronic system that initiates a biochemical reaction that releasesone or more gasses (including, e.g., air) to effect compression ordecompression.

In one or more embodiments of the methods described herein, reducingblood flow to the gastrointestinal tract may include cooling an exteriorsurface of one or more blood vessels that supply the stomach and/orsmall bowel. Such cooling may, for example, cause the blood vessels toconstrict and, thereby, reduce flow. In one or more embodiments, thecooling may be performed by coiling a cooling device around one or moreof the blood vessels that supply the stomach and/or small bowel asdescribed in more detail herein. In one or more embodiments of themethods described herein, blood in blood vessels supplying blood to thestomach and/or the small intestine may be selectively directly cooled torestrict flow.

In one or more embodiments, cooling may be used in ways that do notinvolve direct cooling of blood. In one or more embodiments, the coolingof nerves could result in reflex vasodilation and, in turn, increase thegradient for flow. Cooling also may simply be used to directly suppressappetite by cooling the blood around the stomach and also increasecaloric needs and possibly increase metabolic rate as a result of thebody needing to increase temperature in response to the cooling.

One illustrative embodiment of a system that may be used to induceweight loss in a patient according to one or more of the methodsdescribed herein is depicted in FIG. 2. The system includes a controller20 that is configured to perform the actions described in connectionwith the methods described herein.

In one or more embodiments, the controller 20 may be connected to aninput device 22 that is configured to receive input from a user/patient.The input device 22 may be a wireless input device that communicateswirelessly with the controller 20 which may be implanted subcutaneouslywithin the patient. Some potential embodiments of wireless input devices22 may include, e.g., smart phones, personal computers, dedicatedwireless input devices, etc. In one or more alternative embodiments, theinput device 22 may be connected to the controller 20 by wiredconnection with the input device 22 being in the form of a switch,pushbutton, etc. In those embodiments in which the input device 22 isconnected to the controller 20 by wired connection, input device 22 mayimplanted subcutaneously within the patient.

In one or more embodiments in which the controller 20 is configured toperform a method that includes a determination that a patient isingesting food, the system may include one or more sensors configured todetect that a patient is ingesting food. In the illustrative embodimentdepicted in FIG. 2, the system may include one or more of: a sensor 23configured to detect distention of and/or pressure increases in thestomach of a patient, a sensor 24 configured to sense swallowing by apatient, and a sensor 25 configured to detect flow of food into thestomach of a patient. Each of the sensors is operably connected to thecontroller 20 to provide input signals indicative of the ingestion offood by a patient.

The system depicted in FIG. 2 also includes an optional blood vesselconstriction device 26 configured to constrict blood flow through ablood vessel 14. The constriction device 26 is operably connected to thecontroller 20 which is, as described in connection with the methodsdescribed herein, configured to operate the constriction device toconstrict blood flow through the blood vessel 14.

Another optional device which may be provided in a system such as thatdepicted in FIG. 2 is a cooling device 28 configured to cool bloodflowing through a blood vessel 14 as described in connection with one ormore of the methods described herein. The cooling device 28 is operablyconnected to the controller 20 which is, as described in connection withthe methods described herein, configured to operate the cooling deviceto cool blood flowing through the blood vessel 14. In the depictedillustrative embodiment, the cooling device 28 is in the form of acoiled device coiled around the blood vessel 14, with coolant passingthrough the coiled device 28 two remove thermal energy from the bloodvessel 14 and, therefore, from the blood passing through the bloodvessel 14.

In one or more embodiments of the methods described herein, the bloodflowing through a blood vessel may be cooled as opposed to cooling theexterior surface of the blood vessel. For example, in one or moreembodiments, the cooling may be performed by locating a perfusionballoon in a blood vessel and supplying cooling fluid within theperfusion balloon to reduce the temperature of blood flowing through theblood vessel past the perfusion balloon. One illustrative embodiment ofa perfusion balloon used to cool blood flowing through a blood vessel isdepicted in FIG. 3. In that figure, blood flows through the blood vessel114 in which a perfusion balloon 128 is located. The direction of bloodflow is indicated by the arrow located within the interior 130 of theperfusion balloon 128. The perfusion balloon 128 includes an outerjacket 132 through which a cooling fluid flows to remove thermal energyfrom the blood flowing through the interior 130 of the perfusion balloon128. The cooling fluid flowing through jacket 132 may flow in the samedirection as the blood flowing through the interior 130 of the perfusionballoon 128 or in the opposite direction. In one or more embodiments,the perfusion balloon 128 may operate to both mechanically constrictflow through the blood vessel 114 as well as cool the blood flowingthrough that blood vessel.

In one or more embodiments of the methods described herein, reducingblood flow to the gastrointestinal tract may include sensing an increasein blood flow in one or more blood vessels that supply the stomachand/or small bowel; and diverting flow away from the one or more bloodvessels after sensing (based on, e.g., dynamic change in vessel size,actual vessel caliber, implantable perivascular ultrasound or laserDoppler, electromagnetic intravascular sensor, etc.) the increase inblood flow in the one or more blood vessels thereby decrease the bloodflow to the stomach.

In one or more embodiments of the systems and methods described hereinin which Doppler sensing techniques are used to measure velocity ofblood flow in a blood vessel, the velocity is related to diameter of theblood vessel. The more a blood vessel is constricted (for a given flowrate), the higher the velocity of blood flowing through that vessel, andthe more the blood vessel is dilated, the lower the velocity of bloodflowing through the vessel for the same flow rate. Doppler sensingcould, in one or more embodiments, be used to make sure that blood flowvelocity is set at a certain level. A potential advantage of thatapproach could include avoiding the need for a separate sensor todetect, e.g., gastric motility, food intake, etc. A potentialdisadvantage of this approach is that it presupposes that the totalamount of blood flow through a blood vessel is constant. However byincorporating vessel diameter measurements, flow rate can be easilycalculated. In one or more embodiments of the systems and methodsdescribed herein, the Doppler sensor may be advantageously placed in thevenous system intravascularly to detect flow either through the vein orfrom the neighboring artery while an external device could be placed forcompression using any of the iterations mentioned herein for the artery.If a sensing device is placed intravascularly, one or more embodimentscould be to prepare these sensors with material that prevents bloodclotting.

In one or more embodiments of the systems and methods described herein,warming of the surrounding vessels may be needed to increase blood flowother than to the organ of interest, e.g., the stomach. At the sametime, cooling may be desired, as described herein, along the artery (orvein—see below) of interest to control blood flow. To achieve these dualpurposes and, at the same time, provide for rapid (e.g., nearinstantaneous) cooling, one or more embodiments of the systems andmethods described herein may use the Peltier/Seebeck effects.

Using the Seebeck approach would, e.g., be primarily for generating anelectrical signal as feedback when the temperature difference issufficient between the surrounding tissue (warmer) and the periarterialsurface (cooler). This temperature difference using a simple Seebeckgenerator would, in one or more embodiments, give rise to a signal thatwould, in turn, shut the device off or reduce the rate of thermalcontrol/regulation. In effect, placement of Seebeck generator in suchembodiments could function as a detector of blood flow through a vesseland/or into selected tissue. As the blood flow increased, an electriccurrent (signal) could, in one or more embodiments, be generated as afunction of the difference in temperature between the two sides of theelement. This temperature change could, therefore, be used in one ormore embodiments as an electronic switch or control mechanism asdescribed herein.

The Peltier component of such a system and/or method would, in one ormore embodiments, cause the cooling itself using, e.g., a standardbattery-capacitor and generator system or simple power supply that mightbe implanted (potentially inductively charged nocturnally via a chargerunder the mattress, etc.). One potential disadvantage of thermoelectricgenerators is that warming occurs on one surface as cooling occurs onanother surface (typically on two opposing surfaces). This phenomenonmay be used, in one or more embodiments, to advantage by cooling thevessels and/or tissue that are closest to one surface of the device (to,e.g., limit blood flow) and warming vessels and/or tissue the other(e.g., opposite) surface to cause vasodilation. The result may be, inone or more embodiments, reduced blood flow to the stomach and enhancedearly satiety. This effect may be amplified if the device isstrategically placed, for example, cooling a blood vessel and/or tissuenear one surface of the device to limit blood flow, while warmingappropriate nerve bundles near the other surface of the device tomodulate nerve traffic. Alternatively, the reverse effects could beemployed, e.g., the nerve bundles could be cooled to impede conduction,while the blood vessels and/or other tissues are warmed.

In one or more embodiments of the methods described herein, reducingblood flow to the gastrointestinal tract comprises eluting a drug (e.g.,vasodilators and/or vasoconstricting agents depending on the particularvessel) to reduce flow through one or more blood vessels that supply thestomach and/or small bowel.

In one or more embodiments, direct electrical stimulation of, e.g., astent coated with one or more drugs, could give rise to vesselconstriction and/or or directly promote satiety could be released onreceipt of the electrical impulse (e.g., electrical mediation of drugelution).

In one or more embodiments of the methods described herein, reducingblood flow to the gastrointestinal tract comprises expanding one or moreblood vessels that do not supply the stomach and/or small bowel butrather supply other organs, as well as blood vessels (i.e., veins) thatdrain blood from the GI tract. This diversion will functionally limitthe blood flow to the stomach and/or small bowel. One example of such anapproach could be timed according to gut distention, where blood goes tothe small intestine when food is in the stomach and vice versa. Thisapproach may create a relative deficiency to the area where food needsto be absorbed.

In one or more embodiments of the methods described herein, reducingblood flow to the gastrointestinal tract comprises reducing the flow ofblood away from the gastrointestinal tract. It is theorized thatreducing the flow of blood away from the gastrointestinal tract mayreduce the rate at which blood is delivered to the gastrointestinaltract.

In one or more embodiments of the methods described herein, reducingblood flow to the gastrointestinal tract comprises cooling one or moreof: stomach, small bowel, and one or more nerves (e.g., vagus) organglia (e.g., celiac) associated with the stomach and/or small bowel.In the methods described thus far, inducing weight loss has beendiscussed in the context of detecting when a patient is ingesting foodand reducing blood flow to one or more portions of the gastrointestinaltract in an effort to induce weight loss. In another approach, one ormore embodiments of methods of inducing weight loss may involve reducingblood flow to the gastrointestinal tract by ablating one or more gastricsupply blood vessels to limit dilation of the blood vessels to increaseflow after the ablating. It is theorized that limiting dilation of theblood vessels will reduce flow that would normally increase after theingestion of food and during processing of that food within thegastrointestinal tract.

In one or more embodiments of the systems and methods described herein,the autonomic modulation, either through stimulation blockade orablation may potentially be used alone to control blood flow. In one ormore embodiments, a device could be internal/intravascular (vein orartery) or external with, e.g., a cuff-type electrode around thevascular trunks that would include neural bundles which therefore can bestimulated. In such an embodiment, the sensing arm could be a separatesensor that senses one or more of blood flow, gastric motility, glucose,etc. (although in one or more embodiments, the sensor could beincorporated into the effector arm of the device). In other words, thesystem/method could be configured to monitor neural traffic in atemplate that is kept normal for that patient during rest, eating,sleep, etc. When a characteristic trigger associated with food ingestionis sensed, stimulation/blockade will be performed and, in turn, havereflex vascular changes that may promote early satiety.

In one or more alternative systems/methods, the functioning may not bebased on feedback indicative of the patient eating. In one or moreembodiments, for example, the system/method may involve baseline phasicstimulation to increase afferent signaling of satiety, as well as, e.g.,increasing vascular tone through the efferent autonomic nerves. The samedevice could, in one or more embodiments, be used also for directconstriction of the vascular smooth muscle.

In one or more embodiments of systems/methods using ablation, this couldbe done by a one-time procedure or an implanted device where theablation is done by the same battery that does the stimulation (DC andDC phasic waveforms). In one or more embodiments, the ablation is notnecessarily permanent. It may involve stunning of neurotransmissionbecause of, e.g., reversible electroporation.

In one or more embodiments of inducing weight loss by ablating one ormore blood vessels, the ablating (using, e.g., radiofrequency energy,high intensity ultrasound energy, microwave energy, cryothermal energy,transection, photodynamic therapy (PDT), intravascular sclerosant, etc.)is configured to cause fibrosis of the one or more blood vessels thatsupply the stomach and/or small bowel, wherein the fibrosis limitsdilation of the blood vessels to increase flow.

In one or more embodiments of the systems and methods described herein,fibrosis could be facilitated on the vascular wall by ablating eitherinternally or externally. The extent of fibrosis may cause no fixedlimitation in terms of blood flow (e.g., stenosis is not necessarilycaused), but may limit blood flow by stiffening the vessel wall andlimiting the vasodilation and promotional blood flow that occurs as areflex on, e.g., ingesting food.

In addition to inducing weight loss in methods that involve detectingwhen a patient is ingesting food and reducing blood flow to one or moreportions of the gastrointestinal tract or by ablating one or more bloodvessels supplying the gastrointestinal tract, another approach toinducing weight loss as described herein may involve reducing blood flowto the gastrointestinal tract by ablating one or more nerves selectedfrom the group of: celiac ganglion, superior mesenteric, inferiormesenteric, and hepatic.

In one or more embodiments in which one or more nerves are ablated toinduce weight loss, the ablation may be performed using one or more of:direct current electroporation, microwave energy, and radio-frequencyenergy.

In addition to inducing weight loss in methods that involve detectingwhen a patient is ingesting food and reducing blood flow to one or moreportions of the gastrointestinal tract, by ablating one or more bloodvessels supplying the gastrointestinal tract, or by ablating one or morenerves as described herein, another approach to inducing weight loss asdescribed herein may involve reducing blood flow to the gastrointestinaltract by stimulating one or more peri-arterial nerves to causevasoconstriction of one or more gastric supply blood vessels. Yetanother potential method for inducing weight loss as described hereinmay include reducing blood flow to the gastrointestinal tract by pacingone or more peri-arterial nerves to cause vasoconstriction of one ormore blood vessels that supply the stomach and/or small bowel.

In one or more embodiments of the systems and methods described herein,stimulation, electroporation, direct radiofrequency energy application,and other thermal approaches, including cooling, of the ganglia (e.g.,celiac, mesenteric, hepatic, etc.) could provide indirect effects onsatiety by, e.g., changing cellular glucose intake, promotingglycogenolysis, and possibly gluconeogenesis from fat breakdown that maybe similar to the effects seen during starvation, exercise, andadrenergic stimulation (via, e.g., the hepatic and related ganglia).These effects may be beneficial and intended/purposeful beyond effectsof satiety. In one or more embodiments, improvement of metabolism mayindirectly help with obesity, diabetes, possibly hypertension and themetabolic syndrome could potentially be affected through the directneuroregulatory systems and methods.

In one or more embodiments of the systems and methods described herein,cooling of tissue may be used for the autonomic nerves to produceelectroporation without the use of DC current. In one or moreembodiments, this effect could result in increased vascular tone atcertain locations and decreased vascular tone in others where blood flowis to be promoted. In some instances, there may be combined effects herewith cooling directly affecting the vessel, and providing beneficialeffects on the perivascular nerves.

Disclosure of any patents, patent documents, and publications identifiedherein are incorporated by reference in their entirety as if each wereindividually incorporated. To the extent there is a conflict ordiscrepancy between this document and the disclosure in any suchincorporated document, this document will control.

Illustrative embodiments of the systems and methods are discussed hereinsome possible variations have been described. These and other variationsand modifications in the invention will be apparent to those skilled inthe art without departing from the scope of the invention, and it shouldbe understood that this invention is not limited to the illustrativeembodiments set forth herein. Accordingly, the invention is to belimited only by the claims provided below and equivalents thereof. Itshould also be understood that this invention also may be suitablypracticed in the absence of any element not specifically disclosed asnecessary herein.

1-12. (canceled)
 13. A method of inducing weight loss, the methodcomprising reducing blood flow to the gastrointestinal tract by ablatingone or more blood vessels that supply the stomach and/or small bowel tolimit dilation of the blood vessels to increase flow after the ablating.14. A method according to claim 13, wherein the ablating is configuredto cause fibrosis of the one or more blood vessels that supply thestomach and/or small bowel, wherein the fibrosis limits dilation of theblood vessels to increase flow. 15-18. (canceled)
 19. A system forinducing weight loss, the system comprising: a controller operablyconnected to one or more input devices, wherein the controller isconfigured to determine that a patient is ingesting food; and one ormore blood flow constriction devices operably connected to thecontroller, the one or more blood flow constriction devices configuredto reduce blood flow to the gastrointestinal tract.
 20. A systemaccording to claim 19, wherein the one or more input devices compriseone or more of: a sensor configured to detect distention and/orincreased pressure in a stomach, a sensor configured to detectswallowing, and a sensor configured to detect flow into a stomach.
 21. Asystem according to claim 19, wherein the one or more input devicescomprise a direct input device actuated by a patient to provide a signalto the controller that food is being ingested.
 22. A system according toclaim 19, wherein the one or more blood flow constriction devicescomprises a device configured to mechanically constrict one or moreblood vessels that supply the stomach and/or small bowel.
 23. A systemaccording to claim 19, wherein the one or more blood flow constrictiondevices comprises a device configured to cool an exterior surface of oneor more blood vessels that supply the stomach and/or small bowel.
 24. Asystem according to claim 23, wherein the one or more blood flowconstriction devices is coiled around the exterior surface of the one ormore blood vessels that supply the stomach and/or small bowel.
 25. Asystem according to claim 19, wherein the one or more blood flowconstriction devices comprises a perfusion balloon configured to coolblood flowing through a blood vessel in which the perfusion balloon islocated.